These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21494614)

  • 1. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
    Ekström EJ; Sherwood V; Andersson T
    PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated loss of SFRP2 enhances melanoma cell invasion via Wnt signaling.
    Luo X; Wei B; Chen A; Zhao H; Huang K; Chen J
    Am J Transl Res; 2016; 8(3):1502-9. PubMed ID: 27186276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
    Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.
    Linnskog R; Jönsson G; Axelsson L; Prasad CP; Andersson T
    Mol Oncol; 2014 Dec; 8(8):1365-78. PubMed ID: 24954857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
    Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
    Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
    PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
    O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
    J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
    Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma.
    Lin YW; Shih YL; Lien GS; Suk FM; Hsieh CB; Yan MD
    Dis Markers; 2014; 2014():351863. PubMed ID: 24591760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
    Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
    Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
    Jin Z; Zhao C; Han X; Han Y
    BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.
    Weeraratna AT; Jiang Y; Hostetter G; Rosenblatt K; Duray P; Bittner M; Trent JM
    Cancer Cell; 2002 Apr; 1(3):279-88. PubMed ID: 12086864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
    Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
    Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion.
    Jobe NP; Åsberg L; Andersson T
    Mol Oncol; 2021 Jul; 15(7):1835-1848. PubMed ID: 33969605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.
    Xiao Q; Yang Y; Zhang X; An Q
    Tumour Biol; 2016 May; 37(5):6315-21. PubMed ID: 26628297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.